semaglutide for obesity baton rouge Louisiana lawmakers are considering a bill that would expand Medicaid access to GLP-1 drugs treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Semaglutide Approved for Type 2

Zhou J, Yang Y, Xie Z, Lu D, Huang J, Lan L et al (2024) Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4 + T cell reduction and immune activation

The goal isn't reaching the highest dose fastest

Akomaning, E

Oral medications can sometimes cause nausea or appetite suppression more noticeably in the stomach, whereas injections bypass the GI tract initially

As a glucagon-like peptide-1 (GLP-1) agonist, this medicine: Aids in weight loss Helps manage blood sugar levels Lowers A1c (a measure of glucose control over the previous 2 to 3 months) Improves insulin sensitivity Fights insulin resistance Despite these benefits, it is approved solely for weight loss, not as a diabetes medication

GLP-1 increases from bypass procedures can diminish